Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Current Urology Reports
|
January 23, 2003
Antisense oligonucleotide therapy for urologic tumors
Ingo Kausch, Andreas Böhle
Expert Review of Anticancer Therapy
|
October 6, 2006
Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer
Ingo Kausch, Christian Doehn, Dieter Jocham
Aktuelle Urologie
|
June 3, 2010
[Quality of life after radical cystectomy - an overview and analysis of a contemporary series]
T Severin, P Bub, D Jocham, et al.
Journal of Endourology
|
July 13, 2011
Destruction of stone extraction basket during an in vitro lithotripsy--a comparison of four lithotripters
Jens Cordes, Birgit Lange, Dieter Jocham, et al.
Current Urology Reports
|
June 27, 2002
Immune gene therapy in urology
Ingo Kausch, Peter Ardelt, Andreas Böhle, et al.
International Urology and Nephrology
|
September 1, 2005
Papillary urothelial bladder carcinoma associated with osteoclast-like giant cells
Stefan Krüger, Reiner Johannisson, Ingo Kausch, et al.
Oncology
|
July 15, 2005
Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma
Stefan Krüger, Karl Sotlar, Ingo Kausch, et al.
Urology
|
January 18, 2006
Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma
Stefan Krüger, Anne Mahnken, Ingo Kausch, et al.
European Urology
|
March 19, 2005
P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma
Stefan Krüger, Anne Mahnken, Ingo Kausch, et al.
Anticancer Research
|
April 9, 2005
Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications
Stefan Krüger, Irina Lange, Ingo Kausch, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Current Urology Reports
|
January 23, 2003
Antisense oligonucleotide therapy for urologic tumors
Ingo Kausch, Andreas Böhle
Expert Review of Anticancer Therapy
|
October 6, 2006
Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer
Ingo Kausch, Christian Doehn, Dieter Jocham
Aktuelle Urologie
|
June 3, 2010
[Quality of life after radical cystectomy - an overview and analysis of a contemporary series]
T Severin, P Bub, D Jocham, et al.
Journal of Endourology
|
July 13, 2011
Destruction of stone extraction basket during an in vitro lithotripsy--a comparison of four lithotripters
Jens Cordes, Birgit Lange, Dieter Jocham, et al.
Current Urology Reports
|
June 27, 2002
Immune gene therapy in urology
Ingo Kausch, Peter Ardelt, Andreas Böhle, et al.
International Urology and Nephrology
|
September 1, 2005
Papillary urothelial bladder carcinoma associated with osteoclast-like giant cells
Stefan Krüger, Reiner Johannisson, Ingo Kausch, et al.
Oncology
|
July 15, 2005
Expression of KIT (CD117) in renal cell carcinoma and renal oncocytoma
Stefan Krüger, Karl Sotlar, Ingo Kausch, et al.
Urology
|
January 18, 2006
Value of clusterin immunoreactivity as a predictive factor in muscle-invasive urothelial bladder carcinoma
Stefan Krüger, Anne Mahnken, Ingo Kausch, et al.
European Urology
|
March 19, 2005
P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma
Stefan Krüger, Anne Mahnken, Ingo Kausch, et al.
Anticancer Research
|
April 9, 2005
Protein expression and gene copy number analysis of topoisomerase 2alpha, HER2 and P53 in minimally invasive urothelial carcinoma of the urinary bladder--a multitissue array study with prognostic implications
Stefan Krüger, Irina Lange, Ingo Kausch, et al.
Page
of 3